OCS
Price:
$11.09
Market Cap:
$504.42M
Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medications for various ocular conditions, addressing both the anterior and posterior segments of the eye. A key asset in its therapeutic portfolio is OCS-01, a topical formulation of dexamethasone, currently progressing through Phase 3 clinical trials for the management of diabetic macular edema. Additionally, OCS-02, a topically administered biological candidate, is engaged in Phase 2b clinical studies to treat keratoconjunctivitis sicca, commonly known as dry eye disease. The company is also advancing OCS-05, an innovative neuroprotective agent, which tar...[Read more]
Industry
Biotechnology
IPO Date
2021-05-18
Stock Exchange
NASDAQ
Ticker
OCS
According to Oculis Holding AG’s latest financial reports and current stock price. The company's current Enterprise Value is 442.29M. This represents a change of -48.43% compared to the average of 857.69M of the last 4 quarters.
The mean historical Enterprise Value of Oculis Holding AG over the last ten years is 448.14M. The current 442.29M Enterprise Value has changed 9.77% with respect to the historical average. Over the past ten years (40 quarters), OCS's Enterprise Value was at its highest in in the March 2026 quarter at 1.19B. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.
Average
448.14M
Median
383.00M
Minimum
244.58M
Maximum
750.20M
Discovering the peaks and valleys of Oculis Holding AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 144.10%
Maximum Annual Enterprise Value = 750.20M
Minimum Annual Increase = -40.17%
Minimum Annual Enterprise Value = 244.58M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 750.20M | 25.66% |
| 2024 | 597.02M | 144.10% |
| 2023 | 244.58M | -40.17% |
| 2022 | 408.83M | 14.46% |
| 2021 | 357.16M | 7.89% |
The current Enterprise Value of Oculis Holding AG (OCS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
530.60M
5-year avg
471.56M
10-year avg
448.14M
Oculis Holding AG’s Enterprise Value is less than Xencor, Inc. (1.08B), less than Kodiak Sciences Inc. (1.79B), less than AnaptysBio, Inc. (2.45B), less than UroGen Pharma Ltd. (1.53B), less than Phathom Pharmaceuticals, Inc. (812.47M), less than Nurix Therapeutics, Inc. (1.46B), less than Nektar Therapeutics (1.17B), less than Sana Biotechnology, Inc. (737.35M), less than BridgeBio Oncology Therapeutics Inc. (570.82M), less than Mind Medicine (MindMed) Inc. (2.44B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.08B | $914.17M | |
| 1.79B | $1.80B | |
| 2.45B | $2.42B | |
| 1.53B | $1.45B | |
| 812.47M | $827.07M | |
| 1.46B | $1.47B | |
| 1.17B | $1.16B | |
| 737.35M | $745.82M | |
| 570.82M | $620.83M | |
| 2.44B | $1.56B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oculis Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oculis Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Oculis Holding AG's Enterprise Value?
What is the highest Enterprise Value for Oculis Holding AG (OCS)?
What is the 3-year average Enterprise Value for Oculis Holding AG (OCS)?
What is the 5-year average Enterprise Value for Oculis Holding AG (OCS)?
How does the current Enterprise Value for Oculis Holding AG (OCS) compare to its historical average?